Literature DB >> 22811530

HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent.

Takuya Naruto1, Hiroyuki Gatanaga, George Nelson, Keiko Sakai, Mary Carrington, Shinichi Oka, Masafumi Takiguchi.   

Abstract

We investigated the effect of HLA class I alleles on clinical parameters for HIV-1 disease progression in the Japanese population, where two strongly protective alleles, HLA-B*57 and HLA-B*27, are virtually nonexistent. HLA-B alleles showed a dominant role, primarily through HLA-B*67:01 and the HLA-B*52:01-C*12:02 haplotype. Neither a rare-allele nor a heterozygote advantage was found, suggesting that the effect of HLA alleles in the Japanese population is either different from those observed in Africans and Caucasians or undetectable due to limited power.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22811530      PMCID： PMC3457252          DOI： 10.1128/JVI.00689-12

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  13 in total

1.  HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women.

Authors:  C Costello; J Tang; C Rivers; E Karita; J Meizen-Derr; S Allen; R A Kaslow
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

2.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

3.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

4.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

5.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.

Authors:  X Gao; G W Nelson; P Karacki; M P Martin; J Phair; R Kaslow; J J Goedert; S Buchbinder; K Hoots; D Vlahov; S J O'Brien; M Carrington
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

6.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.

Authors:  Alasdair Leslie; Philippa C Matthews; Jennifer Listgarten; Jonathan M Carlson; Carl Kadie; Thumbi Ndung'u; Christian Brander; Hoosen Coovadia; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

8.  Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.

Authors:  S Saito; S Ota; E Yamada; H Inoko; M Ota
Journal:  Tissue Antigens       Date:  2000-12

9.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 10.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739
View more
  26 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 3.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

4.  HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03.

Authors:  Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

5.  HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.

Authors:  Takayuki Chikata; Giang Van Tran; Hayato Murakoshi; Tomohiro Akahoshi; Ying Qi; Vivek Naranbhai; Nozomi Kuse; Yoshiko Tamura; Madoka Koyanagi; Sachiko Sakai; Dung Hoai Nguyen; Dung Thi Nguyen; Ha Thu Nguyen; Trung Vu Nguyen; Shinichi Oka; Maureen P Martin; Mary Carrington; Keiko Sakai; Kinh Van Nguyen; Masafumi Takiguchi
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.

Authors:  Aniqa Shahid; Alex Olvera; Gursev Anmole; Xiaomei T Kuang; Laura A Cotton; Montserrat Plana; Christian Brander; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

7.  Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Authors:  Hayato Murakoshi; Madoka Koyanagi; Takayuki Chikata; Mohammad Arif Rahman; Nozomi Kuse; Keiko Sakai; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

8.  Host-specific adaptation of HIV-1 subtype B in the Japanese population.

Authors:  Takayuki Chikata; Jonathan M Carlson; Yoshiko Tamura; Mohamed Ali Borghan; Takuya Naruto; Masao Hashimoto; Hayato Murakoshi; Anh Q Le; Simon Mallal; Mina John; Hiroyuki Gatanaga; Shinichi Oka; Zabrina L Brumme; Masafumi Takiguchi
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

Authors:  Beatrice Ondondo; Hayato Murakoshi; Genevieve Clutton; Sultan Abdul-Jawad; Edmund G-T Wee; Hiroyuki Gatanaga; Shinichi Oka; Andrew J McMichael; Masafumi Takiguchi; Bette Korber; Tomáš Hanke
Journal:  Mol Ther       Date:  2016-01-08       Impact factor: 11.454

10.  Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.

Authors:  Hayato Murakoshi; Nozomi Kuse; Tomohiro Akahoshi; Yu Zhang; Takayuki Chikata; Mohamed Ali Borghan; Hiroyuki Gatanaga; Shinichi Oka; Keiko Sakai; Masafumi Takiguchi
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.